Resolvin D5
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: Yes


Resolvin D5
Description:
Resolvin D5 is a prolytic mediator (SPM) with anti-inflammatory activity derived from oxidized lipids DHA. Resolvin D5 inhibits Th17 cell differentiation and promotes regulatory T cell differentiation, and inhibits CD4+ T cell proliferation. Resolvin D5 attenuates osteoclast differentiation and interferes with osteoclastogenesis. Resolvin D5 also regulates ERK phosphorylation and nuclear translocation of NF-kappaB. Resolvin D5 could be used in rheumatoid arthritis research[1][2].UNSPSC:
12352211Hazard Statement:
H302, H315, H319, H335Target:
ERK; NF-κBType:
Natural ProductsRelated Pathways:
MAPK/ERK Pathway; NF-κB; Stem Cell/WntApplications:
COVID-19-immunoregulationField of Research:
Inflammation/ImmunologyAssay Protocol:
https://www.medchemexpress.com/resolvin-d5.htmlConcentration:
277.40 μM * 50 μL in EthanolPurity:
98.3Solubility:
10 mM in DMSOSmiles:
CC/C=C\C[C@H](O)/C=C/C=C\C/C=C\C=C\[C@@H](O)C/C=C\CCC(O)=OMolecular Formula:
C22H32O4Molecular Weight:
360.49Precautions:
H302, H315, H319, H335References & Citations:
[1]Yamada H, et al. Effect of resolvin D5 on T cell differentiation and osteoclastogenesis analyzed by lipid mediator profiling in the experimental arthritis. Sci Rep. 2021 Aug 27;11 (1) :17312.|[2]Chun HW, et al. Resolvin D5, a Lipid Mediator, Inhibits Production of Interleukin-6 and CCL5 Via the ERK-NF-κB Signaling Pathway in Lipopolysaccharide-Stimulated THP-1 Cells. J Microbiol Biotechnol. 2020 Jan 28;30 (1) :85-92.Shipping Conditions:
Dry IceStorage Conditions:
-80°CScientific Category:
Natural ProductsClinical Information:
No Development ReportedCAS Number:
[578008-43-2]
